EORTC at ISOQOL Annual Conference: President’s Award and 12 EORTC abstracts

The International Society for Quality of Life Research (ISOQOL) is an international academic society, which aims to advance the study of health-related quality of life and other patient-reported outcomes. ISOQOL will be holding its 25th Annual Conference in Dublin Ireland from October 24 to 27, 2018. Members of the EORTC QLG will be presenting a total of 12 abstracts for this year’s conference. We would also like to congratulate Dr. Andrew Bottomley for being the recipient of this year’s President’s Award for his work in advancing HRQOL research and his outstanding contributions to the Society.


  • Setting Standards for Analysis of Patient Reported Outcomes and Quality of Life Data for International Cancer Clinical Trials (SISAQOL consortium): Progress update

Presentation Number: Individual presentation in the “Minimizing Research Waste and Maximising the Impact of Patient Reported Outcome Trial Results” Symposium

Speaker: Andrew Bottomley (Belgium)

Date: 26.10.2018 – Lecture Time: 11:15 – Location: Pembroke & Herbert, Ground Floor

Oral Presentations

  • Evidence-based approach to determine meaningful change in scores of the EORTC QLQ-C30 in breast and head and neck cancer: on behalf of the EORTC Breast, Head and Neck and Quality of Life Groups

Presentation Number: 101.4

Speaker: Jammbe Z Musoro (Belgium)

Date: 25.10.2018 – Lecture Time: 2:44pm – Location: Meeting Room 1 + 2

  • Establishing the European Norm for the health-related quality of life scales of the EORTC Computer-Adaptive Test and new reference values for the QLQ-C30 based on a population survey of 15,386 persons across 13 European countries, the USA, and Canada

Presentation Number: 106.4

Speaker: Sandra Nolte (Germany)

Date: 25.10.2018 – Lecture Time: 5:04pm – Location: Pembroke & Herbert, Ground Floor

  • Improving standards of patient reported outcomes analysis: developing a consensus taxonomy of key research objectives – a SISAQOL initiative

Presentation Number: 203.4

Speaker: Madeline Pe* (Belgium)

Date: 26.10.2018 – Lecture Time: 2:59pm – Location: Pembroke & Herbert, Ground Floor

*New investigator oral presentation finalist

  • Phase I and II development of an EORTC QOL cancer survivorship assessment strategy: issue generation and construction of provisional questionnaires

Presentation Number: 301.1

Speaker: Marieke van Leeuwen (The Netherlands)

Date: 27.10.2018 – Lecture Time: 3:55pm – Location: Meeting Room 1 + 2, Second Floor

  • Qualitative evidence on the content validity of EORTC QLQ-C30: Initial findings

Presentation Number: 304.2

Speaker: Kim Cocks (UK)

Date: 27.10.2018 – Lecture Time: 4:13pm – Location: Pembroke & Herbert, Ground Floor

Poster Presentations

  • Quality of life as an outcome in EORTC clinical trials: 15 years of clinical trial research

Poster Number: 1004

Poster Presenter: Irina Ghislain* (Belgium)

Date: 25.10.2018 – Lecture Time: 3:25pm – Location: Lansdowne Room, Ground Floor

*Outstanding poster award finalist

  • Organizing the EORTC Item Library: A Mixed Methods: Exploratory Content Analysis

Poster Number: 2025

Poster Presenter: Claire Piccinin (Belgium)

Date: 26.10.2018 – Lecture Time: 10:35am – Location: Lansdowne Room, Ground Floor

  • Translations of item lists created with the EORTC Item Library: updated translation and review procedure

Poster Number: 2029

Poster Presenter: Dagmara Kulis (Belgium)

Date: 26.10.2018 – Lecture Time: 10:35am – Location: Lansdowne Room, Ground Floor

  • International validation of the EORTC QLQ-CAT

Poster Number: 2033

Poster Presenter: Morten Petersen (Denmark)

Date: 26.10.2018 – Lecture Time: 10:35am – Location: Lansdowne Room, Ground Floor

  • Development of thresholds for clinical importance for the EORTC QLQ-C30 and the computer-adaptive EORTC measures

Poster Number: 3043

Poster Presenter: Fanny Loth (Austria)

Date: 27.10.2018 – Lecture Time: 9:45am – Location: Lansdowne Room, Ground Floor

  • Reference Values for EORTC QLQ-C30 in Early and Metastatic Breast Cancer

Poster Number: 3047

Poster Presenter: Justyna Mierzynska (Belgium)

Date: 27.10.2018 – Lecture Time: 9:45am – Location: Lansdowne Room, Ground Floor

Back to news list

Related News

  • EORTC Completes Patient Recruitment to Study of Treatment for unresectable or metastatic melanoma

  • In Memoriam: Dr Martin Charles Mihm

  • The 1500th patient has been enrolled in the E²-RADIatE cohort OLIGOCARE (RP-1822)

  • PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

  • Long-term follow-up of chemoradiotherapy treatment in glioma patients shows significantly increased survival

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older patients with acute myeloid leukemia

  • Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma

  • EORTC and Alliance Healthcare’s continued partnership in support of SPECTA clinical research infrastructure

  • Results of radiotherapy quality assurance in the PEACE-1 trial show high adherence to protocol

  • EORTC presents new precision medicine research results at AACR 2022